SATB2

Chr 2AD

SATB homeobox 2

Also known as: C2DELq32q33, DEL2Q32Q33, GLSS

This gene encodes a DNA binding protein that specifically binds nuclear matrix attachment regions. The encoded protein is involved in transcription regulation and chromatin remodeling. Defects in this gene are associated with isolated cleft palate and cognitive disability. Alternate splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Feb 2010]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismAD1 OMIM phenotype
Clinical SummarySATB2
🧬
Gene-Disease Validity (ClinGen)
SATB2 associated disorder · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

📋
ClinVar Variants
209 unique Pathogenic / Likely Pathogenic· 236 VUS of 927 total submissions
📖
GeneReview available — SATB2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

gnomad: TimeoutError: The operation was aborted due to timeout

Population Genetics & Constraint

Constraint data not available from gnomAD.

Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveSATB2-related Glass syndromeLOFAD

This gene — mechanism propensity

DN
0.16100th %ile
GOF
0.2497th %ile
LOF
0.88top 5%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median · 1 literature citation · 70% of P/LP variants are LoF · ClinGen HI: Sufficient evidence for dosage pathogenicity
DN1 literature citation

Literature Evidence

DNThis phenotype was accompanied by osteoporosis, fractures, and tibial bowing in two previously reported adult patients; each possessed SATB2 mutations either predicted or demonstrated to escape nonsense-mediated decay, suggesting that the additional bone defects result from a dominant negative effec1
LOFThe recent identification of SATB2 as a candidate gene responsible for the craniofacial dysmorphologies associated with deletions and translocations at 2q32-q33, one of only three regions of the genome for which haploinsufficiency has been significantly associated with isolated cleft palate, led us 2

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

927 submitted variants in ClinVar

Classification Summary

Pathogenic129
Likely Pathogenic80
VUS236
Likely Benign346
Benign80
Conflicting31
129
Pathogenic
80
Likely Pathogenic
236
VUS
346
Likely Benign
80
Benign
31
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
107
15
7
0
129
Likely Pathogenic
39
38
3
0
80
VUS
2
217
16
1
236
Likely Benign
0
29
88
229
346
Benign
0
44
31
5
80
Conflicting
31
Total148343145235902

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

49 pathogenic / likely-pathogenic (of 54) ClinVar copy-number / structural variants overlap SATB2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

SATB2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →